Previous close | 17.90 |
Open | N/A |
Bid | 23.70 |
Ask | 26.60 |
Strike | 110.00 |
Expiry date | 2024-05-17 |
Day's range | 17.90 - 17.90 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Tandem Diabetes stock rocketed Friday after the insulin pump-maker topped first quarter expectations. But DaVita stock reversed lower.
DaVita's (DVA) robust segmental revenues drive its first-quarter performance.
DaVita Inc. (NYSE:DVA) Q1 2024 Earnings Call Transcript May 2, 2024 DaVita Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good evening. My name is Michelle, and I will be your conference facilitator today. At this time, I would […]